What 10 Analyst Ratings Have To Say About RxSight
What 10 Analyst Ratings Have To Say About RxSight
10 位分析师评级对 RxSight 有何看法
Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on RxSight (NASDAQ:RXST) in the last three months.
在过去三个月中，有10位分析师公布了RxSight（纳斯达克股票代码：RXST）的评级，提供了从看涨到看跌的不同视角。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $65.6, a high estimate of $75.00, and a low estimate of $54.00. Observing a 19.03% increase, the current average has risen from the previous average price target of $55.11.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为65.6美元，最高估计为75.00美元，低估值为54.00美元。目前的平均价格上涨了19.03％，已从之前的平均目标价55.11美元上涨。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
An in-depth...
对分析...
登录免费看全文
登录/注册